Sign up Australia
Proactive Investors - Run By Investors For Investors
Sector: Pharma & Biotech
Landos Biopharma (PRIVATE-NA:LANDO)

Landos Biopharma

Landos Biopharma, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a novel, locally-acting small molecule targeting inflammatory bowel disease (IBD) that is expected to enter clinical testing for Crohn’s disease in 2018. Landos also has a...

Landos Biopharma

Interactive graph

col 3
col 4
col 5
col 6

Landos Biopharma Timeline


© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use